| 000 | 01833cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223032253.0 | ||
| 008 | 190502s2018 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.15.Ph.D.2018.Mo.A | ||
| 100 | 0 | _aMohamed Salem Hussein Mohamed Elaalem | |
| 245 | 1 | 0 |
_aAnti-müllerian hormone, follistatin peptide and their role in polycystic ovary syndrome in Egyptian women / _cMohamed Salem Hussein Mohamed Elaalem ; Supervised Ehab Mohamed Soliman , Yahia Mohamed Elfaissal , Dina Mohamed Refaat Dakhly |
| 246 | 1 | 5 | _aهرمون الأنتي موليريان و بروتين الفوليستاتين ودورهما في متلازمة المبيض المتعدد الأكياس في السيدات المصريات |
| 260 |
_aCairo : _bMohamed Salem Hussein Mohamed Elaalem , _c2018 |
||
| 300 |
_a153 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics | ||
| 520 | _aAnti-Müllerian hormone (AMH) and Follistatin (FST) are produced in the granulosa cells of the ovary as well as other tissues and having important role in regard to regulation of growth and development of follicles. The measurement of AMH and FST has been applied to a wide array of clinical applications | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAnti-Müllerian hormone (AM) | |
| 653 | 4 | _aFollistatin | |
| 653 | 4 | _aPolycystic ovary syndrome | |
| 700 | 0 |
_aDina Mohamed Refaat Dakhly , _eSupervisor |
|
| 700 | 0 |
_aEhab Mohamed Soliman , _eSupervisor |
|
| 700 | 0 |
_aYahia Mohamed Elfaissal , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAsmaa _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c71745 _d71745 |
||